Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New hypoxic cytotoxin from Evanston Hospital

May 15, 1997

PAK-104P reverses both P-glycoprotein- and MRP-mediated MDR

May 15, 1997

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

May 15, 1997

Nippon Shinyaku characterizes novel sulfonamide antitumor agent

May 15, 1997

Pharmacokinetics and tissue distribution of TOP-53

May 15, 1997

Samjin characterizes novel antitumor agent

May 14, 1997

In vitro effects of combinations of tubulin-interacting agents and S-16020-2

May 14, 1997

In vivo growth arrest of mammary carcinoma by ibuprofen

May 14, 1997

Dual H1/NK1 antagonist for allergic rhinitis from HMR

May 14, 1997

MMP inhibitor from British Biotech effective against oxidant-induced lung injury

May 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.